Clinical outcomes in non-small cell lung cancer patients with an ultra-high expression of programmed death ligand-1 treated using pembrolizumab as a first-line therapy: A retrospective multicenter cohort study in Japan.
Saved in:
| Title: | Clinical outcomes in non-small cell lung cancer patients with an ultra-high expression of programmed death ligand-1 treated using pembrolizumab as a first-line therapy: A retrospective multicenter cohort study in Japan. |
|---|---|
| Authors: | Edahiro R; Department of Thoracic Oncology, National Hospital Organization Osaka Toneyama Medical Center, Toyonaka, Japan., Kanazu M; Department of Thoracic Oncology, National Hospital Organization Osaka Toneyama Medical Center, Toyonaka, Japan., Kurebe H; Department of Thoracic Oncology, National Hospital Organization Osaka Toneyama Medical Center, Toyonaka, Japan., Mori M; Department of Thoracic Oncology, National Hospital Organization Osaka Toneyama Medical Center, Toyonaka, Japan., Fujimoto D; Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan., Taniguchi Y; Department of Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan., Suzuki H; Department of Thoracic Oncology, Osaka Habikino Medical Center, Osaka, Japan., Hirano K; Department of Respiratory Medicine, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan., Yokoyama T; Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki, Japan., Morita M; Department of Respiratory Medicine, Kobe City Medical Center West Hospital, Kobe, Japan., Fukuda Y; Department of Respiratory Medicine, Himeji Medical Center, Himeji, Japan., Uchida J; Department of Respiratory Medicine, Osaka General Medical Center, Osaka, Japan., Makio T; Department of Respiratory Medicine, Itami City Hospital, Itami, Japan., Tamiya M; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan. |
| Source: | PloS one [PLoS One] 2019 Jul 31; Vol. 14 (7), pp. e0220570. Date of Electronic Publication: 2019 Jul 31 (Print Publication: 2019). |
| Publication Type: | Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31365588 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Clinical outcomes in non-small cell lung cancer patients with an ultra-high expression of programmed death ligand-1 treated using pembrolizumab as a first-line therapy: A retrospective multicenter cohort study in Japan. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Edahiro+R%22">Edahiro R</searchLink>; Department of Thoracic Oncology, National Hospital Organization Osaka Toneyama Medical Center, Toyonaka, Japan.<br /><searchLink fieldCode="AU" term="%22Kanazu+M%22">Kanazu M</searchLink>; Department of Thoracic Oncology, National Hospital Organization Osaka Toneyama Medical Center, Toyonaka, Japan.<br /><searchLink fieldCode="AU" term="%22Kurebe+H%22">Kurebe H</searchLink>; Department of Thoracic Oncology, National Hospital Organization Osaka Toneyama Medical Center, Toyonaka, Japan.<br /><searchLink fieldCode="AU" term="%22Mori+M%22">Mori M</searchLink>; Department of Thoracic Oncology, National Hospital Organization Osaka Toneyama Medical Center, Toyonaka, Japan.<br /><searchLink fieldCode="AU" term="%22Fujimoto+D%22">Fujimoto D</searchLink>; Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.<br /><searchLink fieldCode="AU" term="%22Taniguchi+Y%22">Taniguchi Y</searchLink>; Department of Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Suzuki+H%22">Suzuki H</searchLink>; Department of Thoracic Oncology, Osaka Habikino Medical Center, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Hirano+K%22">Hirano K</searchLink>; Department of Respiratory Medicine, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Yokoyama+T%22">Yokoyama T</searchLink>; Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki, Japan.<br /><searchLink fieldCode="AU" term="%22Morita+M%22">Morita M</searchLink>; Department of Respiratory Medicine, Kobe City Medical Center West Hospital, Kobe, Japan.<br /><searchLink fieldCode="AU" term="%22Fukuda+Y%22">Fukuda Y</searchLink>; Department of Respiratory Medicine, Himeji Medical Center, Himeji, Japan.<br /><searchLink fieldCode="AU" term="%22Uchida+J%22">Uchida J</searchLink>; Department of Respiratory Medicine, Osaka General Medical Center, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Makio+T%22">Makio T</searchLink>; Department of Respiratory Medicine, Itami City Hospital, Itami, Japan.<br /><searchLink fieldCode="AU" term="%22Tamiya+M%22">Tamiya M</searchLink>; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2019 Jul 31; Vol. 14 (7), pp. e0220570. <i>Date of Electronic Publication: </i>2019 Jul 31 (<i>Print Publication: </i>2019). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31365588 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pone.0220570 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e0220570 Titles: – TitleFull: Clinical outcomes in non-small cell lung cancer patients with an ultra-high expression of programmed death ligand-1 treated using pembrolizumab as a first-line therapy: A retrospective multicenter cohort study in Japan. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Edahiro R – PersonEntity: Name: NameFull: Kanazu M – PersonEntity: Name: NameFull: Kurebe H – PersonEntity: Name: NameFull: Mori M – PersonEntity: Name: NameFull: Fujimoto D – PersonEntity: Name: NameFull: Taniguchi Y – PersonEntity: Name: NameFull: Suzuki H – PersonEntity: Name: NameFull: Hirano K – PersonEntity: Name: NameFull: Yokoyama T – PersonEntity: Name: NameFull: Morita M – PersonEntity: Name: NameFull: Fukuda Y – PersonEntity: Name: NameFull: Uchida J – PersonEntity: Name: NameFull: Makio T – PersonEntity: Name: NameFull: Tamiya M IsPartOfRelationships: – BibEntity: Dates: – D: 31 M: 07 Text: 2019 Jul 31 Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1932-6203 Numbering: – Type: volume Value: 14 – Type: issue Value: 7 Titles: – TitleFull: PloS one Type: main |
| ResultId | 1 |
